Literature DB >> 23878285

In vivo 39K MR imaging of human muscle and brain.

Reiner Umathum1, Manuela B Rösler, Armin M Nagel.   

Abstract

PURPOSE: To implement potassium 39 ((39)K) magnetic resonance (MR) imaging with a 7-T MR imaging system and to evaluate its feasibility for in vivo imaging of human muscle and brain.
MATERIALS AND METHODS: Three healthy volunteers were examined with approval of the ethical review board of Heidelberg University. Written informed consent was obtained from all volunteers. Because the available 7-T MR imaging system did not support (39)K, a frequency conversion scheme was developed and connected to the imaging unit. The standard X-nucleus frequency of lithium 7 (115 MHz) was converted to the frequency of (39)K at 7 T (14 MHz). Relaxation times of healthy thigh muscle and brain tissue were estimated by using multiple-echo and inversion-recovery sequences. Data analysis was conducted with a nonlinear least squares curve fitting tool. In vivo (39)K MR imaging of healthy human thigh muscle and brain was performed.
RESULTS: With use of the custom-built frequency conversion scheme, (39)K MR imaging is feasible with a commercially available 7-T MR imaging system. Nominal spatial resolutions of 8 × 8 × 16 mm(3) and 9.5 × 9.5 × 9.5 mm(3) were achieved for human thigh muscle and brain, respectively. Acquisition time was 30 minutes for both muscle and brain tissue. The measured potassium concentration (uncorrected for fat fraction) of thigh muscle tissue (112-124 mmol/L) lies within the expected range.
CONCLUSION: In vivo (39)K MR imaging in humans can be performed in clinically feasible measurement times (approximately 30 minutes) with voxel sizes of approximately 1 mL. RSNA, 2013

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23878285     DOI: 10.1148/radiology.13130757

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  [Functional MRI 2.0. ²³Na and CEST imaging].

Authors:  S Haneder; S Konstandin
Journal:  Radiologe       Date:  2016-02       Impact factor: 0.635

2.  Electrodynamics and radiofrequency antenna concepts for human magnetic resonance at 23.5 T (1 GHz) and beyond.

Authors:  Lukas Winter; Thoralf Niendorf
Journal:  MAGMA       Date:  2016-04-20       Impact factor: 2.310

3.  Improved T*₂ determination in 23Na, 35Cl, and 17O MRI using iterative partial volume correction based on 1H MRI segmentation.

Authors:  Sebastian C Niesporek; Reiner Umathum; Thomas M Fiedler; Peter Bachert; Mark E Ladd; Armin M Nagel
Journal:  MAGMA       Date:  2017-05-26       Impact factor: 2.310

Review 4.  Toward 20 T magnetic resonance for human brain studies: opportunities for discovery and neuroscience rationale.

Authors:  Thomas F Budinger; Mark D Bird; Lucio Frydman; Joanna R Long; Thomas H Mareci; William D Rooney; Bruce Rosen; John F Schenck; Victor D Schepkin; A Dean Sherry; Daniel K Sodickson; Charles S Springer; Keith R Thulborn; Kamil Uğurbil; Lawrence L Wald
Journal:  MAGMA       Date:  2016-05-18       Impact factor: 2.310

5.  A Frequency Translation System for Multi-Channel, Multi-Nuclear MR Spectroscopy.

Authors:  Stephen E Ogier; Matthew Wilcox; Sergey Cheshkov; Ivan E Dimitrov; Craig R Malloy; Mary P McDougall; Steven M Wright
Journal:  IEEE Trans Biomed Eng       Date:  2020-12-21       Impact factor: 4.538

Review 6.  Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.

Authors:  Francesco Sanvito; Antonella Castellano; Andrea Falini
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

Review 7.  Use of cardiac magnetic resonance to detect changes in metabolism in heart failure.

Authors:  William D Watson; Jack J J Miller; Andrew Lewis; Stefan Neubauer; Damian Tyler; Oliver J Rider; Ladislav Valkovič
Journal:  Cardiovasc Diagn Ther       Date:  2020-06

8.  Quantitative 1H and 23Na muscle MRI in Facioscapulohumeral muscular dystrophy patients.

Authors:  Teresa Gerhalter; Benjamin Marty; Lena V Gast; Katharina Porzelt; Rafael Heiss; Michael Uder; Stefan Schwab; Pierre G Carlier; Armin M Nagel; Matthias Türk
Journal:  J Neurol       Date:  2020-10-12       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.